Elinger Gali, Hasson-Ohayon Ilanit, Barkalifa Eran, Boelen Paul A, Peri Tuvia
Department of Psychology, Bar-Ilan University, Ramat Gan, Israel.
Department of Psychology, Ben-Gurion University, Beer Sheva, Israel.
Eur J Psychotraumatol. 2021 Mar 30;12(1):1896126. doi: 10.1080/20008198.2021.1896126.
: Prolonged grief disorder (PGD) is a chronic and disabling condition that affects approximately 10% of non-traumatically bereaved people. Narrative reconstruction (NR), originally designed for the treatment of posttraumatic stress disorder (PTSD), is a time-limited integrative therapy consisting of exposure to the loss memory, detailed written reconstruction of the loss memory narrative, and an elaboration of the personal significance of that memory for the bereaved. : This pilot study examined the efficacy of NR therapy in reducing symptoms in bereaved people diagnosed with PGD. : Ten PGD patients participated in the study and were treated with 16 weekly sessions of NR. PGD, PTSD, and depression symptoms, as well as levels of loss integration, were assessed at pre-treatment, post-treatment, and at a 3-month follow-up. : Following NR, participants showed significant reductions in PGD, depression, and PTSD symptoms, and elevated levels of trauma integration. Symptoms showed further improvement at the three-month follow-up. : These findings provide preliminary evidence for the feasibility and efficacy of NR in treating PGD. Narrative reconstruction therapy requires further evaluation in randomized controlled trials.
持续性悲伤障碍（PGD）是一种慢性致残性疾病，约10%的非创伤性 bereaved者受其影响。叙事重构（NR）最初设计用于治疗创伤后应激障碍（PTSD），是一种限时综合疗法，包括接触丧失记忆、详细书面重构丧失记忆的叙事，以及阐述该记忆对 bereaved者的个人意义。：这项试点研究考察了NR疗法在减轻被诊断为PGD的 bereaved者症状方面的疗效。：10名PGD患者参与了该研究，并接受了为期16周的NR治疗。在治疗前、治疗后和3个月随访时评估PGD、PTSD和抑郁症状以及丧失整合水平。：接受NR治疗后，参与者的PGD、抑郁和PTSD症状显著减轻，创伤整合水平提高。症状在3个月随访时进一步改善。：这些发现为NR治疗PGD的可行性和疗效提供了初步证据。叙事重构疗法需要在随机对照试验中进一步评估。
